Cargando…
Prognostic factors in a T3 bladder cancer trial. Co-operative Urological Cancer Group.
Information on primary tumour size, status of the pelvic lymph nodes, histological type and macroscopic tumour appearance, as well as age and sex, was available at presentation for 394 patients in the Co-operative Urological Cancer Group's prospective randomised trial for T3 cancer of the urina...
Autores principales: | Babiker, A., Shearer, R. J., Chilvers, C. E. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1989
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2247062/ https://www.ncbi.nlm.nih.gov/pubmed/2930712 |
Ejemplares similares
-
The clinical epidemiology of superficial bladder cancer. Dutch South-East Cooperative Urological Group.
por: Kiemeney, L. A., et al.
Publicado: (1993) -
Operative urology
Publicado: (1991) -
Prognostic Value of the New Prostate Cancer International Society of Urological Pathology Grade Groups
por: Offermann, Anne, et al.
Publicado: (2017) -
Clinical Significance of Serological and Urological Levels of Bladder Cancer-Specific Antigen-1 (BLCA-1) in Bladder Cancer
por: Wang, Zhiyong, et al.
Publicado: (2018) -
IS TESTOSTERONE PROGNOSTIC IN PROSTATE CANCER TREATMENT? THE UROLOGICAL STANDPOINT.
por: Sorić, Tomislav, et al.
Publicado: (2019)